The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CUPID (64Cu-TLX592 phase I PK, biodistribution and dosimetry): A proof-of-concept study of TLX592-targeted alpha therapy in prostate cancer.
 
Nat Lenzo
Employment - GenesisCare
Stock and Other Ownership Interests - Telix Pharmaceuticals
 
Anne Capp
Employment - GenesisCare
 
Aviral Singh
Employment - GenesisCare
 
Giuseppe Cardaci
Employment - GenesisCare
 
Neel Patel
Employment - Telix Pharmaceuticals
Stock and Other Ownership Interests - Telix Pharmaceuticals
 
Michael Wheatcroft
Employment - Telix Pharmaceuticals
Leadership - Telix Pharmaceuticals
Stock and Other Ownership Interests - Telix Pharmaceuticals
 
David Cade
Employment - Telix Pharmaceuticals
Leadership - Telix Pharmaceuticals
Stock and Other Ownership Interests - Telix Pharmaceuticals